vs
Laird Superfood, Inc.(LSF)与泛美白银(USAS)财务数据对比。点击上方公司名可切换其他公司
泛美白银的季度营收约是Laird Superfood, Inc.的1.4倍($19.1M vs $13.3M),Laird Superfood, Inc.净利率更高(-13.2% vs -82.3%,领先69.2%),Laird Superfood, Inc.同比增速更快(15.0% vs -28.0%)
Laird Superfood是一家主营植物基功能性超级食品的企业,产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等,面向健康意识较强的消费群体,主要在北美市场通过电商及线下零售渠道销售,主打可持续采购的清洁配方。
泛美白银是一家总部位于加拿大的矿业企业,业务布局集中在拉丁美洲,在墨西哥、秘鲁、玻利维亚、阿根廷多国持有运营矿山及其他矿产开发项目,是美洲地区重要的贵金属开采企业。
LSF vs USAS — 直观对比
营收规模更大
USAS
是对方的1.4倍
$13.3M
营收增速更快
LSF
高出43.0%
-28.0%
净利率更高
LSF
高出69.2%
-82.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $13.3M | $19.1M |
| 净利润 | $-1.8M | $-15.7M |
| 毛利率 | 34.1% | 34.2% |
| 营业利润率 | -13.5% | — |
| 净利率 | -13.2% | -82.3% |
| 营收同比 | 15.0% | -28.0% |
| 净利润同比 | -341.4% | 2.8% |
| 每股收益(稀释后) | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LSF
USAS
| Q4 25 | $13.3M | — | ||
| Q3 25 | $12.9M | $19.1M | ||
| Q2 25 | $12.0M | — | ||
| Q1 25 | $11.7M | — | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $11.8M | $26.5M | ||
| Q2 24 | $10.0M | — | ||
| Q1 24 | $9.9M | — |
净利润
LSF
USAS
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-975.1K | $-15.7M | ||
| Q2 25 | $-362.2K | — | ||
| Q1 25 | $-156.2K | — | ||
| Q4 24 | $-398.4K | — | ||
| Q3 24 | $-166.1K | $-16.2M | ||
| Q2 24 | $-239.1K | — | ||
| Q1 24 | $-1.0M | — |
毛利率
LSF
USAS
| Q4 25 | 34.1% | — | ||
| Q3 25 | 36.5% | 34.2% | ||
| Q2 25 | 39.9% | — | ||
| Q1 25 | 41.9% | — | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 43.0% | 23.6% | ||
| Q2 24 | 41.8% | — | ||
| Q1 24 | 40.0% | — |
营业利润率
LSF
USAS
| Q4 25 | -13.5% | — | ||
| Q3 25 | -7.7% | — | ||
| Q2 25 | -3.3% | — | ||
| Q1 25 | -1.9% | — | ||
| Q4 24 | -4.1% | — | ||
| Q3 24 | -2.3% | — | ||
| Q2 24 | -3.4% | — | ||
| Q1 24 | -11.0% | — |
净利率
LSF
USAS
| Q4 25 | -13.2% | — | ||
| Q3 25 | -7.6% | -82.3% | ||
| Q2 25 | -3.0% | — | ||
| Q1 25 | -1.3% | — | ||
| Q4 24 | -3.4% | — | ||
| Q3 24 | -1.4% | -60.9% | ||
| Q2 24 | -2.4% | — | ||
| Q1 24 | -10.3% | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $5.1M | $39.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $11.5M | $50.2M |
| 总资产 | $19.2M | $234.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
LSF
USAS
| Q4 25 | $5.1M | — | ||
| Q3 25 | $5.1M | $39.1M | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $7.0M | — | ||
| Q4 24 | $8.3M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $7.6M | — | ||
| Q1 24 | $7.1M | — |
股东权益
LSF
USAS
| Q4 25 | $11.5M | — | ||
| Q3 25 | $12.8M | $50.2M | ||
| Q2 25 | $13.4M | — | ||
| Q1 25 | $13.3M | — | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $13.1M | $53.1M | ||
| Q2 24 | $12.6M | — | ||
| Q1 24 | $12.7M | — |
总资产
LSF
USAS
| Q4 25 | $19.2M | — | ||
| Q3 25 | $18.9M | $234.7M | ||
| Q2 25 | $20.4M | — | ||
| Q1 25 | $21.5M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $18.8M | — | ||
| Q2 24 | $18.0M | — | ||
| Q1 24 | $17.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $68.4K | $-12.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-41.3M |
| 自由现金流率自由现金流/营收 | — | -216.5% |
| 资本支出强度资本支出/营收 | — | 150.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
LSF
USAS
| Q4 25 | $68.4K | — | ||
| Q3 25 | $1.2M | $-12.5M | ||
| Q2 25 | $-2.8M | — | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | $339.2K | — | ||
| Q3 24 | $305.8K | $2.4M | ||
| Q2 24 | $642.7K | — | ||
| Q1 24 | $-422.3K | — |
自由现金流
LSF
USAS
| Q4 25 | — | — | ||
| Q3 25 | — | $-41.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-11.2M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
LSF
USAS
| Q4 25 | — | — | ||
| Q3 25 | — | -216.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -42.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
LSF
USAS
| Q4 25 | — | — | ||
| Q3 25 | — | 150.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
USAS
暂无分部数据